NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mapmygenome

Mapmygenome

Private
HyderabadHealthcare & Life Scienceshttps://mapmygenome.in/

Last Round

Pre Seed

Mar 10, 2015

Total Funding Raised

$1.1M

Company Overview

Mapmygenome is a genomics company that provides personalized health solutions through at-home DNA tests and diagnostic genomic tests.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

at-home DNA testgenetic counselinggenomic diagnostics23andMe for Indiapharmacogenomicsgut microbiome testprecision medicineIndian genomicswhole genome sequencinghereditary cancer testingpreventive healthcareancestry analysisbiological age testnutrigenomicsmicrobiome analysiscontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mapmygenome Comparables

Compare Mapmygenome with similar companies based on industry and business-model similarity.

Mapmygenome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Mapmygenome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 10, 2015

Key People

Founding team and executive leadership

Anuradha Acharya

CEO

Executive Team

Mapmygenome Investors

Notable investors and investment history

Mapmygenome investors
InvestorRounds
Singapore Angel NetworkPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 36% MoM, reaching 46.1K.

  • May 2, 2025

    Monthly visitors grew 33% MoM, reaching 33.8K.

Mapmygenome Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mapmygenome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mapmygenome's valuation, stock price, and market status.

Firmographic Details

HeadquartersHyderabad
Employee Range123
Year Founded2012
Last FundingMar 10, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.